Compare RDNT & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDNT | MMS |
|---|---|---|
| Founded | 1985 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.7B |
| IPO Year | 1986 | 1997 |
| Metric | RDNT | MMS |
|---|---|---|
| Price | $77.71 | $88.75 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $83.60 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 1.0M | 642.9K |
| Earning Date | 11-09-2025 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.34% |
| EPS Growth | N/A | ★ 10.42 |
| EPS | N/A | ★ 5.51 |
| Revenue | $1,969,599,000.00 | ★ $5,431,276,000.00 |
| Revenue This Year | $11.77 | $1.71 |
| Revenue Next Year | $10.76 | $4.98 |
| P/E Ratio | ★ N/A | $16.30 |
| Revenue Growth | ★ 11.09 | 2.36 |
| 52 Week Low | $45.00 | $63.77 |
| 52 Week High | $85.84 | $92.50 |
| Indicator | RDNT | MMS |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 59.74 |
| Support Level | $70.31 | $85.78 |
| Resistance Level | $73.52 | $91.09 |
| Average True Range (ATR) | 3.00 | 1.99 |
| MACD | 0.36 | 0.13 |
| Stochastic Oscillator | 92.67 | 63.47 |
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.